Intellectual Property Cases
Cases 1 - 10 of 98
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 1:2024cv00039
Plaintiff: Regeneron Pharmaceuticals, Inc.
Counter Claimant: Amgen, Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified: AFLIBERCEPT PATENT LITIGATION
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 2:2024cv00264
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Amgen, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AMGEN INC. et al v. SANDOZ INC. et al
as 1:2023cv02406
Plaintiff: AMGEN INC. and AMGEN MANUFACTURING, LIMITED
Defendant: SANDOZ INC., SANDOZ GMBH, LEK PHARMACEUTICALS D.D. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AMGEN INC. et al v. SANDOZ INC. et al
as 2:2023cv02406
Plaintiff: AMGEN INC. and AMGEN MANUFACTURING, LIMITED
Defendant: SANDOZ INC., SANDOZ GMBH, LEK PHARMACEUTICALS D.D. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
OssiFi-Mab LLC v. Amgen Inc.
as 1:2023cv10861
Plaintiff: OssiFi-Mab LLC
Defendant: Amgen Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2023cv00031
Plaintiff: Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant: MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Biotech, Inc. v. Amgen Inc.
as 1:2022cv01549
Plaintiff: Janssen Biotech, Inc.
Defendant: Amgen Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sandoz Inc. v. Amgen Inc. et al We have downloadable decisions or orders for this case
as 2:2022cv05326
Petitioner: Sandoz Inc.
Defendant: Amgen Inc. and Amgen Manufacturing Limited
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
AMGEN INC. v. APOTEX INC.
as 3:2022cv03827
Plaintiff: AMGEN INC.
Defendant: APOTEX INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?